Product Name:3-Hydrazino-6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine

IUPAC Name:5-hydrazinyl-3,4-diazatricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,4,6,11,13-hexaene

CAS:802598-74-9
Molecular Formula:C13H14N4
Purity:95%+
Catalog Number:CM337866
Molecular Weight:226.28

Packing Unit Available Stock Price($) Quantity
CM337866-100mg in stock ƞǕź
CM337866-250mg in stock ǯŭŔ
CM337866-1g 1-2 Weeks ƞƞǯź

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:802598-74-9
Molecular Formula:C13H14N4
Melting Point:-
Smiles Code:NNC1=NN=C2C(CCCC3=CC=CC=C32)=C1
Density:
Catalog Number:CM337866
Molecular Weight:226.28
Boiling Point:
MDL No:
Storage:2-8ºC

Column Infos

Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products